Health
FDA Panel to Consider Peptides Access
FDA scientists have flagged concerns about the efficacy and safety of peptides, which are being supported by RFK Jr. An FDA panel will soon consider easing access to these molecules.
Coverage timeline — 1 article
NPR
Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.
2026-06-30 18:32 UTC